Epidemiology |
Up to 40% of infants within 3 months of age, 1–3% of the general adult population. |
50% of adult population. |
[1–3,22,23] |
Location |
Scalp, retro-auricular area, face (nasolabial folds, upper lip, eyelids, eyebrows), upper chest. |
Scalp. |
[2,7,15] |
Presentation |
Erythematous patches, with large, oily or dry scales. |
White to yellow flakes dispersed on the scalp and hair; without erythema. |
[2,3,26] |
Histology |
Acanthosis, hyperkeratosis, spongiosis, parakeratosis, Malassezia yeasts. |
[3,23,38] |
Vasodilation and perivascular and perifollicular inflammatory infiltration; “shoulder parakeratosis”. |
Subtle neutrophil infiltration or no inflammatory infiltration. |
Treatment |
Antifungal shampoos and topical. |
[2,8,26,47,97] |
Topical corticosteroids, immune modulators, phototherapy, systemic treatment. |
|
Predisposing Factors and causes |
Sebaceous gland activity, fungal colonization, and individual susceptibility (epidermal barrier integrity, host immune response, genetic factors, neurogenic factors and stress, nutrition, etc.). |
[2,3,9,15,26,44,66] |